Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis-Reference-Cited by-同舟云学术

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

Published:2012-04-05 Issue:11 Volume:26 Page:2317-2325
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Comenzo R L,Reece D,Palladini G,Seldin D,Sanchorawala V,Landau H,Falk R,Wells K,Solomon A,Wechalekar A,Zonder J,Dispenzieri A,Gertz M,Streicher H,Skinner M,Kyle R A,Merlini G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012100.pdf

Reference53 articles.

1. Merlini G, Palladini G . Amyloidosis: is a cure possible? Ann Oncol 2008; 19 (Suppl 4): iv63–iv66.

2. Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O’Fallon WM et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992; 79: 1817–1822.

3. Rajkumar SV, Gertz MA . Advances in the treatment of amyloidosis. N Engl J Med 2007; 356: 2413–2415.

4. Lebovic D, Hoffman J, Levine BM, Hassoun H, Landau H, Goldsmith Y et al. Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone. Br J Haematol 2008; 143: 369–373.

5. Palladini G, Kyle RA, Larson DR, Therneau TM, Merlini G, Gertz MA . Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis. Amyloid 2005; 12: 120–126.

Cited by 321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of B cell maturation antigen‐directed CAR T‐cell therapy in patients with relapsed/refractory multiple myeloma and concurrent light chain amyloidosis;European Journal of Haematology;2024-08-27

2. Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?;Expert Review of Hematology;2024-08-20

3. Diagnostic performance of liver stiffness as marker of liver involvement in systemic immunoglobulin light chain (AL) amyloidosis;Annals of Hematology;2024-08-16

4. Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis;Kidney International Reports;2024-07

5. Safety and Efficacy of SGLT2 Inhibitors for Amyloid Light-Chain Cardiomyopathy;Journal of Cardiac Failure;2024-07